These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 19644002)

  • 21. Social cognition.
    Patin A; Hurlemann R
    Handb Exp Pharmacol; 2015; 228():271-303. PubMed ID: 25977087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preclinical research into cognition enhancers.
    Sarter M
    Trends Pharmacol Sci; 2006 Nov; 27(11):602-8. PubMed ID: 16997388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Nootropes (cognition enhancers) and neuroprotectors].
    Vornin TA; Seredenin SB
    Eksp Klin Farmakol; 2007; 70(4):44-58. PubMed ID: 18078043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Using ginseng root and other herbal adaptogens as nootropic drugs].
    Arushanian EB
    Eksp Klin Farmakol; 2008; 71(6):58-66. PubMed ID: 19140520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Navigating the enhancement landscape. Ethical issues in research on cognitive enhancers for healthy individuals.
    Forlini C; Hall W; Maxwell B; Outram SM; Reiner PB; Repantis D; Schermer M; Racine E
    EMBO Rep; 2013 Feb; 14(2):123-8. PubMed ID: 23318628
    [No Abstract]   [Full Text] [Related]  

  • 26. Just treat, or enhance?
    Kennedy D
    Science; 2004 Apr; 304(5667):17. PubMed ID: 15060288
    [No Abstract]   [Full Text] [Related]  

  • 27. Buddhism and neuroethics: the ethics of pharmaceutical cognitive enhancement.
    Fenton A
    Dev World Bioeth; 2009 Aug; 9(2):47-56. PubMed ID: 18312602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroenhancement: wisdom of the masses or "false phronesis"?
    Larriviere D; Williams MA
    Clin Pharmacol Ther; 2010 Oct; 88(4):459-61. PubMed ID: 20856244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuroethical issues in cognitive enhancement.
    Sahakian BJ; Morein-Zamir S
    J Psychopharmacol; 2011 Feb; 25(2):197-204. PubMed ID: 20212064
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroenhancing public health.
    Shaw D
    J Med Ethics; 2014 Jun; 40(6):389-91. PubMed ID: 23793059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Challenging pharmacotherapy in dementia].
    Ihl R
    MMW Fortschr Med; 2009 Mar; 151(13):46-8. PubMed ID: 19504818
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacological cognitive enhancement in healthy people: potential and concerns.
    Hyman S; Volkow N; Nutt D
    Neuropharmacology; 2013 Jan; 64():8-12. PubMed ID: 23145451
    [No Abstract]   [Full Text] [Related]  

  • 33. Cognitive Enhancement: Treating or Cheating?
    Whetstine LM
    Semin Pediatr Neurol; 2015 Sep; 22(3):172-6. PubMed ID: 26358427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Preventive and cessation therapy of mental disorders in patients with the acute coronary syndrome].
    Medvedev VE; Epifanov AV; Zverev KV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(4):42-8. PubMed ID: 22810740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. What should we do about student use of cognitive enhancers? An analysis of current evidence.
    Ragan CI; Bard I; Singh I;
    Neuropharmacology; 2013 Jan; 64():588-95. PubMed ID: 22732441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Begging important questions about cognitive enhancement, again.
    Partridge B; Lucke J; Finnoff J; Hall W
    Am J Bioeth; 2011 Jan; 11(1):14-5. PubMed ID: 21240797
    [No Abstract]   [Full Text] [Related]  

  • 37. Cognitive enhancers--performance or problem?
    Sharp C
    Occup Med (Lond); 2016 Mar; 66(2):88-9. PubMed ID: 26892595
    [No Abstract]   [Full Text] [Related]  

  • 38. Safety and effectiveness of a traditional ginkgo fresh plant extract - results from a clinical trial.
    Bäurle P; Suter A; Wormstall H
    Forsch Komplementmed; 2009 Jun; 16(3):156-61. PubMed ID: 19657199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Use of Pharmacologic Cognitive Enhancers in Competitive Chess.
    Franke AG; Dietz P; Ranft K; Balló H; Simon P; Lieb K
    Epidemiology; 2017 Nov; 28(6):e57-e58. PubMed ID: 28817470
    [No Abstract]   [Full Text] [Related]  

  • 40. [Perspectives on the treatment of organic mental disorders by the use of nootropic agents].
    Litvintsev SV; Shamreĭ VK; Reznik AM; Arbuzov AL
    Voen Med Zh; 2002 May; 323(5):59-62. PubMed ID: 12073844
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.